Table 2. .
Variable | AIH (N = 23) | PSC (N = 11) | P value* |
---|---|---|---|
Chronic hepatitis — no. (%) | .239 | ||
Positive | 22 (96) | 9 (82) | |
Negative | 1 (4) | 2 (18) | |
Plasma cells — no. (%)* | .316 | ||
Positive | 14 (61) | 5 (55) | |
Negative | 9 (31) | 6 (46) | |
Bile duct damage — no. (%) | .519 | ||
Positive | 18 (78) | 8 (73) | |
Negative | 5 (22) | 3 (27) | |
Bile duct proliferation — no. (%)* | .091 | ||
Positive | 22 (100) | 8 (80) | |
Negative | 0 (0) | 2 (20) | |
Concentric fibrosis — no. (%)* | .495 | ||
Positive | 10 (44) | 4 (36) | |
Negative | 15 (57) | 7 (64) | |
Cholestasis — no. (%) | .118 | ||
Positive | 8 (35) | 1 (9) | |
Negative | 15 (65) | 10 (91) | |
Necrosis — no. (%)* | .239 | ||
Positive | 1 (4) | 2 (18) | |
Negative | 22 (96) | 9 (82) | |
Fibrosis stage — no. (%)* | .815 | ||
I | 4 (17) | 3 (27) | |
II | 1 (4) | 1 (9) | |
III | 3 (13) | 1 (9) | |
IV | 15 (65) | 6 (55) |
Add to >100 or <100 due to rounding.
Fisher’s Exact Test.